These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7555613)

  • 1. Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction.
    Yew WW; Chau CH; Wong PC; Lee J; Wong CF; Cheung SW; Chan CY; Cheng AF
    Drugs Exp Clin Res; 1995; 21(2):79-83. PubMed ID: 7555613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction.
    Yew WW; Lee J; Wong PC; Kwan SY
    Int J Clin Pharmacol Res; 1992; 12(4):173-8. PubMed ID: 1297640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of treating patients with destructive pulmonary tuberculosis with liver involvement].
    Novozhylova IO
    Lik Sprava; 1998; (7):121-3. PubMed ID: 10050479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined chemotherapy of toxic hepatitis in patients with pulmonary tuberculosis].
    Frolov VM; Peresadin NA; Pustovoĭ IuG
    Probl Tuberk; 1992; (5-6):30-1. PubMed ID: 1409510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lomefloxacin in phthisiatric practice].
    Grishin VK; Polunina TE
    Antibiot Khimioter; 1998; 43(10):17-8. PubMed ID: 9825104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of Astragalus dasyanthus in lesions of the liver in patients with pulmonary tuberculosis].
    Skakun NP; Blikhar EI; Oleĭnik AN
    Vrach Delo; 1988 Jun; (6):51-4. PubMed ID: 3420913
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 9. [A study of 172 patients with hepatic injury caused by antituberculosis drugs].
    Cheng SQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):571. PubMed ID: 15387923
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis.
    Kennedy N; Fox R; Uiso L; Ngowi FI; Gillespie SH
    J Antimicrob Chemother; 1993 Dec; 32(6):897-902. PubMed ID: 8144431
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatotoxicity to different antituberculosis drug combinations.
    Aziz S; Agha F; Hassan R; Fairoz SA; Hassan K
    J Pak Med Assoc; 1990 Dec; 40(12):290-4. PubMed ID: 2126569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.
    Tostmann A; van den Boogaard J; Semvua H; Kisonga R; Kibiki GS; Aarnoutse RE; Boeree MJ
    Trop Med Int Health; 2010 Feb; 15(2):268-72. PubMed ID: 20409289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of N-acetyl cystein on antituberculosis drug-induced hepatotoxicity.
    Filik L
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):193; author reply 193. PubMed ID: 21228682
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of the plant hepatoprotector Galstena tuberculostatics-induced hepatic lesions: experimental and clinical study].
    Katikova OIu; Asanov BM; Vize-Khripunova MA; Burba EN; Ruzov VI
    Probl Tuberk; 2002; (4):32-6. PubMed ID: 12125250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reamberin in tuberculosis chemotherapy and its effect on liver function].
    Antibiot Khimioter; 2013; 58(3-4):33-6. PubMed ID: 24640150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis.
    Pore SM; Shinde K
    J Postgrad Med; 2014; 60(1):90-2. PubMed ID: 24625953
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of the treatment of patients with pulmonary tuberculosis by the short-term chemotherapy method with reference to the side effects of the drugs].
    Westfal I; Spychalski W; Szelerska-Twardosz H; Grzegorzewska A; Ryszewski W
    Pneumonol Pol; 1988 Apr; 56(4):163-5. PubMed ID: 3412967
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis in patients with surgical complications of pulmonary tuberculosis.
    Ansari MM; Beg MH; Haleem S
    Indian J Chest Dis Allied Sci; 1991; 33(3):133-8. PubMed ID: 1794880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.